Impact of the Appropriateness of Prophylactic Antibiotics toward Surgical Site Infections in Caesarean Sections in Hospital "X" Semarang

Christina Wijayanti, Dwi Hadi Setya Palupi, Vitarani Dwi Ananda Ningrum

Abstract


Caesarean delivery (caesarean section) continues to increase in Indonesia. Surgical Site Infection (SSI) is a serious issue that can increase morbidity and length of hospital stay. The use of prophylactic antibiotics has been proven to prevent the occurrence of surgical site infections (SSI) in caesarean sections. The hospital has established antibiotic use guidelines as the standard for antibiotic therapy and prophylactic antibiotic use in surgical procedures. This study aimed to see how well the use of antibiotics before caesarean sections matched the hospital's guidelines and how this related to the rate of surgical site infections (SSI). The cross-sectional method determined the relationship between the appropriateness of prophylactic antibiotics and the incidence of SSI. The study used retrospective data from caesarean section patients at Hospital "X" Semarang who received prophylactic antibiotics between January 2023 and June 2024. The research results showed no significant relationship (P>0.05) between the appropriateness of prophylactic antibiotic use and the incidence of SSI. The data showed that preventive antibiotics (ampicillin-sulbactam and cefazoline injection) were mostly used correctly in several areas: the right antibiotic was chosen 87% of the time, the correct dosage was used 83% of the time, the right way of giving the injection was followed 92.7% of the time, and the correct length of time for the injection was also followed 92.7% of the time. Nonetheless, there are some discrepancies, namely in the timing of post-cesarean antibiotic therapy (94%), and preventive antibiotic administration (57.7%). During that time, the SSI rate was 2.67%.


Keywords


Cesarean Section; Guidelines For Prophylactic Antibiotic Use; Prophylactic Antibiotics; Surgical Site Infection.

Full Text:

PDF 36-44

References


A. Rohmah and I. A. Rahmawati, “Tingkat Kejadian dan Faktor yang Berhubungan dengan Infeksi Luka Operasi Pasca Sectio Caesarea di Rumah Sakit Umum Daerah Wonosari Incidence and Factors Related to Surgical Site Infection Post-Caesarean Section,” vol. 1, no. 2, pp. 85–94, 2023, doi: 10.28885/bikkm.vol1.iss2.art4.

R. W. Pratiwi, Y. Y. Simanjuntak, and P. R. Veriyanti, “Evaluasi Penggunaan Antibiotik Profilaksis pada Pasien Sectio Caesarea di RSUD Budhi Asih Periode Juni-Desember 2020,” Sainstech Farma J. Sainstech Farm. vol.16 No. 1, vol. 16, no. 1, pp. 22–27, 2020, [Online]. Available: https://ejournal.istn.ac.id/index.php/saintechfarma/article/view/1493%0Ahttps://ejournal.istn.ac.id/index.php/saintechfarma/article/download/1493/989

Kemenkes RI, “Pedoman Pencegahan dan Pengendalian Infeksi di Fasilitas Pelayanan Kesehatan, vol. 4, no. 4, pp. 9–15, 2017.

T. O. Dayo-Dada, A. A. Ojo, and O. A. Akpor, “Prevalence of surgical site infection among caesarean section patients in a teaching hospital in Ekiti State, Nigeria: An eight-year review,” Sci. African, vol. 16, 2022, doi: 10.1016/j.sciaf.2022.e01216.

R. Kemenkes, “Peraturan Menteri Kesehatan Republik Indonesia Nomor 28 tahun 2021 Pedoman Penggunaan Antibiotika,” Kementeri. Kesehat. Republik Indones., vol. 10, no. 2, p. 6, 2021, [Online]. Available: http://www.theseus.fi/handle/10024/341553%0Ahttps://jptam.org/index.php/jptam/article/view/1958%0Ahttp://ejurnal.undana.ac.id/index.php/glory/article/view/4816%0Ahttps://dspace.uii.ac.id/bitstream/handle/123456789/23790/17211077 Tarita Syavira Alicia.pdf?

S. Fajriyah, U. Farida, S. Agustina, L. Winduhani Astuti, and E. Ambar Widyaningrum, “The Use of Prophylactic Antibiotics for Cesarean Section Delivery and The Incident of Surgical Site Infection,” Indones. J. Pharm. Educ., vol. 3, no. 2, pp. 247–255, 2023, doi: 10.37311/ijpe.v3i2.19864.

R. Hardiyanti, “Penggunaan Antibiotik Profilaksis Pada Pasien Sectio Caesarea,” J. Heal. Sci. Physiother., vol. 2, no. 1, pp. 96–105, 2020, doi: 10.35893/jhsp.v2i1.37.

F. F. Khikma and I. Sofwan, “Higeia Journal of Public Health,” Higeia J. Public Heal. Res. Dev., vol. 5, no. 3, pp. 227–238, 2021.

H. M. Salihu, R. E. Wilson, A. P. Alio, and R. S. Kirby, “Advanced maternal age and risk of antepartum and intrapartum stillbirth,” J. Obstet. Gynaecol. Res., vol. 34, no. 5, pp. 843–850, 2008, doi: 10.1111/j.1447-0756.2008.00855.x.

H. K. F. M. POGI, “Pedoman Nasional Pelayanan Kedokteran KETUBAN PECAH DINI,” Clin. Charact. outcome twin gestation Complicat. by preterm premature rupture Membr., 2016.

Setianingsih, S. Zukhri, and N. Indriani, “Faktor-Faktor Yang Mempengaruhi Kejadian Infeksi Daerah Operasi Pada Pasien Post Operasi Sectio Caesarea,” 12th Univ. Res. Colloqium, no. 1, pp. 419–430, 2020.

H. Merriman, Infectious Diseases, Fourth Edi. Elsevier Inc., 2014. doi: 10.1016/B978-1-4557-2896-1.00013-5.

A. Douglas et al., “Plasma and tissue pharmacokinetics of cefazoline in patients undergoing elective and semielective abdominal aortic aneurysm open repair surgery,” Antimicrob. Agents Chemother., vol. 55, no. 11, pp. 5238–5242, 2011, doi: 10.1128/AAC.05033-11.

T. Sumiartini, D. R. Laksmitawati, H. U. Ramadaniati, R. I. Natadidjaja, and R. Asmajaya, “Pengaruh Pemberian Antibiotik terhadap Tanda Infeksi Daerah Operasi Superfisial dan Lama Tinggal Pasien Sectio Caesaria,” J. Biomedika dan Kesehat., vol. 4, no. 1, pp. 5–11, 2021, doi: 10.18051/jbiomedkes.2021.v4.5-11.

Pertiwi. dkk, “View of Cost-Effective Analysis of Ceftriaxone as Prophylactic Antibiotic in Caesarean Section_ Single Dose Versus Multiple Dose.pdf.” Jurnal Ilmu Kefarmasian Indonesia, Jakarta, pp. 176–183, 2022.

H. Cheng, B. P. H. Chen, I. M. Soleas, N. C. Ferko, C. G. Cameron, and P. Hinoul, “Prolonged Operative Duration Increases Risk of Surgical Site Infections: A Systematic Review,” Surg. Infect. (Larchmt)., vol. 18, no. 6, pp. 722–735, 2017, doi: 10.1089/sur.2017.089.

A. Arce-Sillas et al., “Regulatory T Cells: Molecular Actions on Effector Cells in Immune Regulation,” J. Immunol. Res., vol. 2016, 2016, doi: 10.1155/2016/1720827.

CDC, “Surgical Site Infection Event (SSI) Introduction,” Natl. Healthc. Saf. Netw., no. January, pp. 1–39, 2022, [Online]. Available: https://www.cdc.gov/nhsn/pdfs/ps-analysis-resources/ImportingProcedureData.pdf.

A. Ali, D. Gebretsadik, and K. Desta, “Incidence of surgical site infection, bacterial isolate, and their antimicrobial susceptibility pattern among patients who underwent surgery at Dessie Comprehensive Specialized Hospital, Northeast Ethiopia,” SAGE Open Med., vol. 11, 2023, doi: 10.1177/20503121231172345.




DOI: https://doi.org/10.31983/jkb.v15i1.12672

Article Metrics

Abstract view : 47
Download PDF 36-44 : 19

Refbacks

  • There are currently no refbacks.


Abstracted/Indexed by:

Creative Commons License

Jurnal Kebidanan by http://ejournal.poltekkes-smg.ac.id/ojs/index.php/jurkeb is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. 

View My Stats aw